Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma (original) (raw)

• Boring, C.C., Squires, T.S. & Tong, T. Cancer statistics, 1993. CA Cancer J. Clin. 43, 7–26 (1993).
  Article CAS PubMed Google Scholar
• Almoguerra, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549–554 (1988).
  Article Google Scholar
• Hruban, R.H. et al. K-ras oncogene activation in adenocarcinomas of the human pancreas: a study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotlde hybridization. Am. J. Pathol. 143, 545–554 (1993).
  CAS PubMed PubMed Central Google Scholar
• Pellegata, S. et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res. 54, 1556–1560 (1994).
  CAS PubMed Google Scholar
• Redston, M.S. et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopoiymer tracts in DNA microdeletions. Cancer Res. 54, 3025–3033 (1994).
  CAS PubMed Google Scholar
• Seymour, A.B. et al. Allelotype of pancreatic adenocarcinoma. Cancer Res. 54, 2761–2764 (1994).
  CAS PubMed Google Scholar
• El-Deiry, W. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
  Article CAS PubMed Google Scholar
• Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M. & Smith, J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90–98 (1994).
  Article CAS PubMed Google Scholar
• Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–707 (1993).
  Article CAS PubMed Google Scholar
• Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyciin-dependent kinases. Cell 75, 805–816 (1993).
  Article CAS PubMed Google Scholar
• Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704–707 (1993).
  Article CAS PubMed Google Scholar
• Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436–440 (1994).
  Article CAS PubMed Google Scholar
• Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753–756 (1994).
  Article CAS PubMed Google Scholar
• Cannon-Albright, L.A. et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13–p22. Science 258, 1148–1152 (1992).
  Article CAS PubMed Google Scholar
• Bos, J.L. et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 327, 293–297 (1987).
  Article CAS PubMed Google Scholar
• Weber, J.L. & May, P.E. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am. J. hum. Genet. 44, 388–396 (1989).
  CAS PubMed PubMed Central Google Scholar
• Kwaitkowski, K.W., Armour, J., Bale, A.E., Fountain, J.W. & Goudie, D. Report on the second international workshop on hyman chromosome 9. Cytogenet. Cell Genet. 64, 94–103 (1993).
  Google Scholar
• Okamoto, A. et al. Mutations and altered expression of p16INK4 in human cancer. Proc. natn. Acad. Sci. U.S.A. (in the press).
• Cairns, P. et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265, 415–416 (1994).
  Article CAS PubMed Google Scholar
• Spruck, C.H. III et al. p16 gene in uncultured tumours. Nature 370, 183–184 (1994).
  Article PubMed Google Scholar
• Yanagisawa, A. et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res. 53, 953–956 (1993).
  CAS PubMed Google Scholar
• Caldas, C. et al. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 54, 3568–3573 (1994).
  CAS PubMed Google Scholar
• Cameron, J.L. et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am. J. Surg. 161, 120–125 (1991).
  Article CAS PubMed Google Scholar
• Feinberg, A.P. & Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137, 266–267 (1984).
  Article CAS PubMed Google Scholar
• Ruggeri, B. et al. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes. Oncogene 7, 1503–1511 (1992).
  CAS PubMed Google Scholar